N-glycyl-L-IsoleucIne

CAS: 19461-38-2

Ref. 3D-FG39662

Produktinformation

• Name: N-glycyl-L-IsoleucIne
• Synonyme: 110: PN: US20130123467 SEQID: 134 claimed protein, 16: PN: KR20140043582 SEQID: 19 claimed protein, 54: PN: EP2161028 PAGE: 10 claimed protein, <span class="text-smallcaps">L</span>-Isoleucine, N-glycyl-, <span class="text-smallcaps">L</span>-Isoleucine, glycyl-, Glycyl-<span class="text-smallcaps">L</span>-isoleucine, Glycylisoleucine, Isoleucine, N-glycyl-, <span class="text-smallcaps">L</span>-, N-Glycyl-<span class="text-smallcaps">L</span>-isoleucine, glycyl-L-isoleucine, Isoleucine, N-glycyl-, L-, L-Isoleucine, N-glycyl-, L-Isoleucine, glycyl-

Beschreibung

N-glycyl-L-Isoleucine is a molecule that belongs to the group of proline-containing dipeptides. It has been shown to be an effective inhibitor of matrix metalloproteinase production in tissue cultures. In addition, this compound inhibits the synthesis of collagen, which is a key component of connective tissue. N-glycyl-L-Isoleucine also inhibits the uptake and degradation of wild type bacteria by phagocytic cells and enhances the biochemical pathways that break down proteins. This molecule has been shown to have antimicrobial activity against typhimurium and other wild type strains. N-glycyl-L-Isoleucine can be used as an adjuvant for vaccine formulations against infectious diseases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 188.22 g/mol
• Formel: C₈H₁₆N₂O₃
• Reinheit: Min. 95%
• InChl: InChI=1S/C8H16N2O3/c1-3-5(2)7(8(12)13)10-6(11)4-9/h5,7H,3-4,9H2,1-2H3,(H,10,11)(H,12,13)/t5-,7-/m0/s1
• InChI Key: InChIKey=KGVHCTWYMPWEGN-FSPLSTOPSA-N
• SMILES: CC[C@H](C)[C@H](NC(=O)CN)C(=O)O